The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwCAR-T 2019 | Day 1 round up: CAR T-cell products
John Gribben, MD, DSc, FRCPath, FMed Sci, Barts Cancer Institute, London, UK, chairs the day 1 round up of the 1st International Workshop on CAR-T (iwCAR-T), held in Miami, FL, along with Noelle Frey, MD, University of Pennsylvania, Philadelphia, PA, and David Maloney, MD, PhD, Fred Hutchinson Cancer Research Center, Seattle, WA. Hear their thoughts on differences among CAR T-cell products, ethical issues in clinical trials, and product collection and manufacturing.
